The effect of HYPE knock-out on the AMPylome of human OSU-CLL leukemia cells

Leuk Lymphoma. 2024 Feb;65(2):242-249. doi: 10.1080/10428194.2023.2275530. Epub 2024 Jan 24.

Abstract

In humans, AMPylation of cellular proteins is carried out by Huntingtin yeast-interacting protein E (HYPE), activated under conditions of endoplasmic reticulum stress, such as in cancer cells. Extracts of the human chronic lymphocytic leukemia cell line, OSU-CLL, were fractionated using immuno-precipitation with antibodies against adenosine-phosphate and then AMP-Tyr. The proteins isolated were modified with AMP, the 'AMPylome.' AMP-labelled peptides isolated from HYPE wild-type (WT) and HYPE knock-out (KO) cells were identified using tandem mass spectrometry. A total of 213 proteins were identified from WT cell extracts, while only 23 of these were pulled down from KO cells, consistent with the presence of another AMPylator, besides HYPE. The KO cells were more sensitive to fludarabine nucleoside (2-FaraA) than WT cells. Ingenuity Pathway Analysis of the AMPylated proteins identified in WT cells clustered actin binding proteins of the cytoskeleton, and proteins of the RHO GTPase pathway that would jointly stimulate cell proliferation.

Keywords: CLL; fludarabine; ingenuity pathway analysis; leukemia; unfolded protein response.

MeSH terms

  • Adenosine Monophosphate / metabolism
  • Cell Line
  • Endoplasmic Reticulum Stress
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / metabolism
  • Vidarabine

Substances

  • Adenosine Monophosphate
  • Vidarabine